Graduate School of Biomedical Sciences and Department of Molecular Biology, School of Osteopathic Medicine, University of Medicine and Dentistry of New Jersey, Stratford, New Jersey 08084, USA.
J Biol Chem. 2013 Apr 26;288(17):12215-21. doi: 10.1074/jbc.C112.446823. Epub 2013 Mar 25.
Podoplanin (PDPN) is a transmembrane receptor that affects the activities of Rho, ezrin, and other proteins to promote tumor cell motility, invasion, and metastasis. PDPN is found in many types of cancer and may serve as a tumor biomarker and chemotherapeutic target. The intracellular region of PDPN contains only two serines, and these are conserved in mammals including mice and humans. We generated cells from the embryos of homozygous null Pdpn knock-out mice to investigate the relevance of these serines to cell growth and migration on a clear (PDPN-free) background. We report here that one or both of these serines can be phosphorylated by PKA (protein kinase A). We also report that conversion of these serines to nonphosphorylatable alanine residues enhances cell migration, whereas their conversion to phosphomimetic aspartate residues decreases cell migration. These results indicate that PKA can phosphorylate PDPN to decrease cell migration. In addition, we report that PDPN expression in fibroblasts causes them to facilitate the motility and viability of neighboring melanoma cells in coculture. These findings shed new light on how PDPN promotes cell motility, its role in tumorigenesis, and its utility as a functionally relevant biomarker and chemotherapeutic target.
足蛋白(PDPN)是一种跨膜受体,可影响 Rho、ezrin 和其他蛋白的活性,从而促进肿瘤细胞的运动性、侵袭性和转移。PDPN 存在于多种类型的癌症中,可能作为肿瘤生物标志物和化疗靶点。PDPN 的细胞内区域仅包含两个丝氨酸,这些丝氨酸在包括小鼠和人类在内的哺乳动物中是保守的。我们从纯合缺失 Pdpn 敲除小鼠的胚胎中生成细胞,以在明确的(无 PDPN)背景下研究这些丝氨酸与细胞生长和迁移的相关性。我们在此报告,这些丝氨酸中的一个或两个可被蛋白激酶 A(PKA)磷酸化。我们还报告说,将这些丝氨酸转化为不可磷酸化的丙氨酸残基可增强细胞迁移,而将其转化为磷酸模拟天冬氨酸残基则可降低细胞迁移。这些结果表明 PKA 可通过磷酸化 PDPN 来降低细胞迁移。此外,我们还报告,成纤维细胞中 PDPN 的表达会使其在共培养中促进相邻黑色素瘤细胞的运动性和活力。这些发现为 PDPN 如何促进细胞运动性、其在肿瘤发生中的作用以及作为功能相关的生物标志物和化疗靶点的用途提供了新的见解。